Western Blotting Processors Market to surpass US$ 383.7 Million in valuation by 2031

Conventional western blotting processors are relatively inconsistent in terms of the efficiency of detecting protein traces in samples.

 While the technique of western blotting demands time and technical expertise, automation has magnified the process of throughput screening in western blotting, thereby facilitating increasing number of trials and accelerating the experimentation process.

Automated western blotting techniques enable the analysis of several samples at one go, with the only manual task being loading of the sample into the western blotting system.

Automation is currently trending the western blotting processors market, as revealed in a comprehensive research study by Future Market Insights

From an estimated valuation of US$ 235.5 Mn in 2021, the western blotting processors market is projected to reach a market value of just under US$ 329 Mn towards the close of 2031, exhibiting a decadal CAGR of 11.5%, according to the research report by Future Market Insights.

Manufacturers are Accelerating Product Launches and Eyeing Offshoring as a Viable Growth Strategy

The market for western blotting processors is highly competitive with the top companies accounting for a larger part of global sales. Leading companies are acquiring smaller companies and expanding their production capacities to gain a larger share of the global market.

Companies in the western blotting processors market are leveraging the available market opportunities to launch their products in full gear in the global market. One of the market companies leveraged an unexploited demand for point-of-care HIV diagnostics as its key entry strategy in the western blotting processors market.

Product registration followed by commercialisation is accelerating the product launch process and creating healthy competition in the global market for western blotting processors.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7365

Manufacturers of western blotting processors are setting up production facilities in other countries so as to benefit from access to cheap labour and resource expertise, and realign their distribution and customer oriented strategies.

Another key player in the western blotting processors market recently made a strategic investment in the offshore development of its life sciences facility with a mandate to engage in the manufacturing and distribution of molecular biology products to a global clientele.

Increasing Cases of HIV Enabling Western Blotting Processors Market Growth

The number of HIV cases across the world is increasing by the day, causing a burden on the global healthcare industry. Monitoring and controlling the HIV epidemic depends on early detection of anti-HIV antibodies in human blood.

Western blot is a confirmed test that can detect anti-HIV antibodies in blood serum samples. This is one of the factors leading to an increase in the adoption of western blotting processors.

Proteomics is extensively used in the pharmaceuticals industry to identify specific proteins associated with particular diseases, with western blotting finding application in new drug discovery. In the field of medical diagnostics, proteomics is used in the diagnosis of biomarkers that are essentially proteins present in body fluids.

Western blotting helps in quick diagnosis of diseases by identifying proteins that are produced when the human body contracts a disease. Besides the healthcare and pharmaceuticals industry, western blotting also finds application in the agriculture sector to establish protein characterisation in seed quality testing; and in the food and beverages industry to detect whey milk protein in commercial grade soy milk to check for possible adulteration.

Western Blotting Processors Market Growth Challenged by High Costs, Low Innovation, and Unreliability of Automated Devices

Advanced automated western blotting devices such as the high performance western blotting transfer system are highly priced than their traditional counterparts, thereby restricting adoption across several developing economies.

High cost of labour is another challenge in certain regions that continue to carry out protein tests using cheap traditional western blotting processors, thereby leading to time-consuming and high labour cost-inducing processes.

Then again, the global western blotting processors market has not witnessed notable innovation, with very few advanced products launched in recent years.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-7365

Further, results obtained from the western blotting process are not fully reliable or consistent and the devices need to be updated regularly to produce more efficient and reliable results. The aforementioned factors are challenging revenue growth of the global western blotting processors market.

Market SegmentationBy Product Type:

  • Automated Dry Blotting Systems
  • Semi-Dry Blotting Systems
  • Traditional Wet Transfer Blotting Systems

By Application:

  • Agricultural Application
  • Food & Beverages
  • Medical Diagnostics
  • Scientific Research
  • Other Applications

By End Users:

  • Diagnostic laboratories
  • Pharmaceutical and Biotechnology Companies
  • Research & Academic institution
  • Others

By Regions:

  •  North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Western Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Benelux
    • Nordic
    • Rest of Western Europe
  • Eastern Europe
    • Russia
    • Poland
    • Rest of Eastern Europe
  • Asia Pacific excluding China & Japan
    • India
    • Australia & New Zealand
    • ASEAN
    • Rest of Asia- Pacific excluding China & Japan
  • Japan
  • China
  • MEA
    • GCC Countries
    • South Africa
    • Rest of MEA

Ask For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-7365

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

IVD Antibodies Market size is projected to grow at a healthy CAGR of around 7% from 2022 and 2032

[250 Pages Report] The global IVD antibodies market is expected to grow at a healthy CAGR of around 7% between 2022 and 2032, reaching a valuation of nearly US$ 77 billion by 2027. The rising prevalence of chronic and infectious diseases worldwide, as well as the increasing need for early diagnosis of chronic diseases in order to initiate proper treatment, are driving demand for IVD antibodies.

Report Attribute Details
IVD Antibodies Market Estimated Growth Rate (2022-2032) 7% CAGR
IVD Antibodies Market Projected Size (2027) US$ 77 Bn

In vitro diagnostics tests are used in laboratories, healthcare settings or directly by consumers at home for the detection of various diseases, infections and other medical conditions. Various companies in the IVD antibodies market are focusing on mergers and acquisitions with regional players. For example, in Sep. 2018, Summa Equity AB acquired Turku-based HyTest Ltd. whose regional presence in the U.S. and Asia is good. Continuously evolving nature of IVD antibodies market further expected to get maximum traction. Superior capability of the IVD antibodies to detect complex diseases such as cancer and use of IVD antibodies in therapeutic monitoring, evaluating blood safety before transfusion further makes it preferred choice of diagnosis test.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8565
IVD Antibodies Market: Drivers and RestraintsIncreasing incidence of chronic diseases such as HIV, hepatitis, cancer, cardiovascular diseases, etc. expected to drive the growth of IVD antibodies market. Incidence of cancer and cardiovascular diseases is increasing rapidly and hence aging population of world further expected to drive the growth of IVD antibodies market. The ease of use of IVD antibodies for the diagnosis at laboratories, hospitals or even at home further increases patient compliance and makes IVD antibodies preferred choice.

The IVD antibodies market is further driven by increasing research and development funding which in turn improving the outcome of diagnostic tests as well as manufacturing of high end quality IVD antibodies for assays. Manufacturers in the IVD antibodies market are focusing on mergers, acquisitions, collaborations and agreements such as Sebia Inc. one of the major IVD manufacturing company signed an agreement with Janssen Biotech to develop multiple myeloma IVD test. Whereas, low product penetration and higher cost of the IVD antibodies may hamper the potential growth of the market. Although manufacturers are focusing on developing novel IVD antibodies for diagnosis of different diseases but time consuming nature of research and development and tedious product approval process may hamper the growth of market.

IVD Antibodies Market: Overview

The global IVD antibodies market is majorly driven by the increasing chronic disease incidence as well as increasing product penetration in the low and middle income countries. By product type, IVD antibodies market is expected to be dominated by the tumor markers due to high adoption for the diagnosis of malignancies. By the application, the IVD antibodies market is dominated by the cancer due to high number of diagnostic procedures. By end user, IVD antibodies market is dominated by the diagnostic laboratories due to high patient footfall for the disease diagnosis. The increasing R & D expenditure by leading biopharmaceutical companies for the development and evaluation of IVD antibodies for different diagnosis of various diseases expected to impact the market significantly.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-8565

IVD Antibodies Market: Regional Outlook

The global IVD antibodies market is dominated by North America due to higher product penetration. Europe is expected to be the second most lucrative IVD antibodies market due to higher number of diagnostic procedure and favorable reimbursement scenario. Latin America is expected to experience steady market growth due to increasing IVD antibodies adoption for the diagnostic procedures. Asia-Pacific is emerging market in IVD antibodies due to rapidly increasing product penetration, and emerging countries such India and China where healthcare infrastructure evolving rapidly. Middle East and Africa is expected to be least revenue generating IVD antibodies market due to low product penetration as well as limited availability of good healthcare infrastructure in most of the MEA region.

IVD Antibodies Market: Key Players

The key market participants operating in the IVD antibodies market are: Abcam plc., Thermo Fisher Scientific, Rockland Immunochemicals Inc., GenScript, Bio-Rad Laboratories, Inc., SDIX, LLC., Advy Chemical Pvt. Ltd., MEDICAL & BIOLOGICAL LABORATORIES CO., LTD., HyTest Ltd., Abbott and Others

The research report presents a comprehensive assessment of the IVD Antibodies market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to IVD Antibodies market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • IVD Antibodies Market Segments
  • IVD Antibodies Market Dynamics
  • IVD Antibodies Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/8565

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, South Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

IVD Antibodies Market: Segmentation

The global IVD antibodies market is segmented based on the product type, application, end user and region

By product type IVD antibodies market is segmented as:

  • Cardiac Markers
  • Tumor Markers
  • Kidney Injury Markers
  • Infection and Inflammation Antibodies

By application, IVD antibodies market is segmented as:

  • Immunology
  • Cancer
  • Cardiovascular Diseases

By end user IVD antibodies market is segmented as:

  • Hospitals
  • Diagnostic Laboratories
  • Homecare settings
  • Others

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

HIV Antivirals Market is set to reach a valuation of US$ 30.6 Billion in 2022

[300 Pages Report] The global HIV antivirals market is expected to be worth $30.6 billion in 2022, with a CAGR of 4.4 percent during the forecast period (2022-2032). According to a recent study, fixed-dose combinations (FDCs) will account for more than 83 percent of the HIV antivirals market in 2021.

According to Future Market Insights, the global HIV antivirals market was around US$ 29.4 Bn in 2021 and is expected to exhibit a CAGR of close to 4.4% over the forecast period (2022-2032).

The demand for HIV antivirals is increasing due to growing prevalence of HIV across the globe. For instance, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS), approximately 37.7 million people were infected with HIV in the world in 2020.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15095

Market Outlook:

Data Points Market Insights
HIV Antivirals Market Value 2021dg US$ 29.4 Bn
Market Value 2022 US$ 30.6 Bn
Market Value 2032 US$ 47.0 Bn
CAGR 2022-2032 4.4%
Market Share of Top 5 Countries 64.8%

Further, demand for HIV antivirals will also surge amid surging rate of unprotected sex and the use of contaminated needles or syringes. As per the National Youth Risk Behavior Survey provided by the Centers for Disease Control and Prevention (CDC), 38% of the respondents had sexual intercourse, and 9% had four or more sexual partners in the U.S., during high school, in 2019.

Hence, key players are developing generic anti-HIV drugs at cost-effective prices to capitalize on growing demand. For instance, generic versions of Lamivudine, Abacavir, and Efavirenz are available in the U.S. at prices lower than their branded versions. This is expected to create lucrative opportunity for the generic HIV antivirals manufacturers to provide affordable medical facilities in low and middle-income countries.

Key Takeaways from Market Study

  • Fixed-dose combinations (FDCs) segment held over 83.2% market value share in 2021, owing to their ability to improve adherence to an HIV treatment regimen.
  • Hospital pharmacies are the leading sales channel of the HIV antivirals, with over 53% of the market share in 2021, and are anticipated to grow at a CAGR rate of 4. 5% in upcoming decade
  • North America is expected to dominate the global HIV antivirals market, holding a share of 38.7% in 2021.
  • India is expected to lead the growth in South Asia market owing to the growing cases of HIV in the country

Ask from Market Research Expert@ https://www.futuremarketinsights.com/ask-question/rep-gb-15095

“With increasing awareness among the people about HIV causes and symptoms, the HIV antivirals market is set witness positive growth during the forecast period. Hence, key players are developing anti-HIC drugs vaccines to increase their revenue,” says an analyst of Future Market Insights.

Market Competition

Market players are expanding the business through collaborations, and increasing involvement in clinical trials as the key strategy with instances of key companies, such as Merck and Gilead, in order to improve their reach in the market and compete with other key players in forthcoming years. For instance:

  • In October 2021, Merck announced favorable results from two pivotal Phase 3 trials of the investigational, once-daily oral fixed-dose combination pill of doravirine/islatravir (DOR/ISL) in adults with HIV-1 infection.
  • In March 2021, Gilead announced the development and commercialization of long-acting, investigational treatment combinations of Lenacapavir and Islatravir in HIV in association with Merck.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the HIV antiviral market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the product – (fixed-dose combinations (FDCs), integrase strand transfer inhibitors (INSTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), entry inhibitors – CCR5 co-receptor antagonist, protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs), and others), by sales channel (hospital pharmacies, retail pharmacies, and online pharmacies) across seven key regions of the world.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15095

Key Players :

  • ViiV Healthcare
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Genetech, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • AbbVie
  • Cipla
  • Pfizer Inc.
  • Mylan N.V.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Macleods Pharmaceuticals Ltd
  • Emcure Pharmaceuticals Limited
  • Aspen Pharmacare Limited
  • Lupin Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Theratechnologies Inc.
  • Strides Arcolab Limited
  • Hetero labs limited
  • Laurus Laboratories Ltd

Key Market Segments Covered in HIV Antivirals Market Research

By Product:

  • Fixed Dose Combinations (FDCs)
  • Integrase Strand Transfer Inhibitors (INSTIs)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  • Entry Inhibitors – CCR5 co-receptor antagonist
  • Protease Inhibitors (PIs)
  • Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Paediatric Spasticity Treatment Market is likely to register a CAGR of 10% during the forecast period 2022-2032

[324 Pages Report] During the forecast period, the paediatric spasticity treatment market is expected to grow at a CAGR of 10%. Rising demand for combination products such as benzodiazepines, imidazole, and gamma-aminobutyric acid analogues is driving the global paediatric spasticity treatment market. Furthermore, demand for paediatric spasticity treatment is increasing as a result of increased awareness and investment in research and development.

Paediatric Spasticity Treatment: Market InsightsPaediatric Spasticity results due to damage of portion of brain or spinal cord which controls the voluntary movement. When paediatric spasticity occurs due to injury or disease, nerve signals do not reach muscles and continuously contract which causes stiffness and tightness which interfere with movement and speech. Several drugs are available to treat the Paediatric Spasticity, drugs are injected into the affected nerve or the muscle. Physical therapy used to increase strength, improve muscle mobility and muscle coordination, use of braces, and electrical stimulation. Oral medication for treatment of paediatric spasticity is considered when spasticity symptoms gets adverse and start affecting daily muscle functioning. According to estimates from CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network, about 1 in 323 children has been identified with Cerebral Palsy and most (77.4%) of the children identified with CP had spastic CP. 

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9408

Paediatric Spasticity Treatment: Market Dynamics

Increasing awareness, growing research and development for drug development drive the market of paediatric spasticity treatment in the near future. Changing lifestyle, developing new and innovative technology, improving healthcare infrastructure is expected to fuel the paediatric spasticity treatment market in the forecast period. Launch of novel therapeutics and growing per capita income in the emerging economies such as China, Brazil is further drive the paediatric spasticity treatment market.

Despite many factors which drive the global market for paediatric spasticity treatment, various factor which might hinder the growth of paediatric spasticity treatment market include high cost of treatment and low awareness in under developed and developing countries and rigorous regulations for the approval of drug.

Paediatric Spasticity Treatment: Overview

Advancement and development of new therapeutic treatment and growing clinical trials for the paediatric spasticity treatment creates huge opportunity for the paediatric spasticity treatment market to grow in the forecast period. Collaboration and partnership among major players for developing new drugs, increasing funding for the research will drive the market of paediatric spasticity treatment in near future. For instance, in august 2016, FDA Approved Ipsen’s Dysport (abobotulinumtoxina) injection for the treatment of lower limb spasticity in children aged two and older.

Paediatric Spasticity Treatment: Region-wise Outlook

The North America is expected to contribute to a major share in the global paediatric spasticity treatment, owing to increasing population, increasing number of screening procedures, presence of major manufacturers and growing clinical trials. Well-developed healthcare facilities and government funding for drug development further drive the market for paediatric spasticity treatment. Europe contributes for the second largest share with significant growth in the global paediatric spasticity treatment market owing to technological advancement in the treatment coupled with growing adoption of new treatment. Asia Pacific market is primarily driven by the factors such as growing prevalence, increasing population, growing awareness of new treatment options. China is expected to register rapid growth in the paediatric spasticity treatment market, due to large patient pool, availability of new drugs for the paediatric spasticity treatment. Latin America and Middle East & Africa are projected to show sluggish growth in paediatric spasticity treatment market, due to less awareness, lack of adequate healthcare facilities and less developed infrastructure.

Pediatric Spasticity Treatment: Key Players

Some of the key players present in the global pediatric spasticity treatment market are Allergan plc, Ipsen Biopharmaceuticals, Inc., Almirall, S.A, Piramal Critical Care, Inc., Genentech, Inc, Sanofi, Saol Therapeutics, US WorldMeds, LLC among others.

The report covers exhaustive analysis on,

  • Pediatric Spasticity Treatment Market Segments
  • Pediatric Spasticity Treatment Market Dynamics
  • Historical Actual Market Size, 2012 – 2016
  • Pediatric Spasticity Treatment Market Size & Forecast 2016 to 2024
  • Pediatric Spasticity Treatment Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Pediatric Spasticity Treatment Market Drivers and Restraints

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9408

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific Excluding China
  • China
  • Middle East & Africa
Pediatric Spasticity Treatment: Segmentation 

The global Pediatric Spasticity Treatment market is segmented on basis of drug type, distribution channel and geography.

Segmentation by Drug Type

  • Baclofen or Muscle Relaxants
  • Botox
  • Intrathecal Baclofen
  • Clonazepam
  • Diazepam
  • Tizanidine
  • Others

Segmentation by Route Of Administration

  • Oral
  • Injectable

Segmentation by Distribution Channel

  • Hospitals Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Mail Order Pharmacies

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Dental Chairs Market is projected to reach US$ 851 Million by 2032

[250 Pages Report] The global dental chair market is valued at US$ 516.5 Mn in 2022 and is expected to reach US$ 851 Mn by 2032, expanding at a CAGR of 5.1% between 2022 and 2032. According to Future Market Insights, a market research and competitive intelligence provider, global dental chair sales has increased at a CAGR of 4.9% over the last half-decade.

The improvement of technology has led in an increase in the adoption rate of dental chairs. The modern dental chair has unrivaled characteristics that assist both the dental expert and the patient in operating and remaining calm during the operation. Recently, dual-position touchpad controls have been installed on both sides of the top backrest for convenience of access. There is an option to add a unit-mounted touchpad, wireless foot control, and distant wireless touchpad to the twin touchpad controls. Advanced features are expected to drive further demand for dental chairs.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15083

Market growth is expected to be boosted by oral health diseases. The oral illness affects roughly 3.5 Bn people worldwide, according to the Global Burden of Disease Study, with caries of permanent teeth being the most frequent. Caries of permanent teeth affect an estimated 2.3 Bn individuals worldwide, whereas caries of primary teeth affect more than 530 Mn children. The rising frequency of oral problems is expected to raise the demand for dental examination and treatment chairs.

Key Takeaways from Market Study

Global dental chairs market is expected to witness an absolute dollar opportunity of US$ 334.6 Mn between 2022 and 2032 Among key types, powered dental chairs account for the largest share and revenue through this segment is projected to grow at a CAGR of 5.8% during 2022 – 2032 Among product type, revenue through ceiling mounted design of dental chairs is projected to witness a CAGR growth of 5.8% during the forecast period North America led the dental chairs sales worldwide with a share of over 35% in 2021

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15083

Winning Strategy

Increased frequency of dental infections and periodontal diseases, surged need for dental care facilities, and dental surgical treatments, as well as technological improvements, are driving the growth of the dental chair market. However, the industry is expected to be hampered by high prices associated with modern dental chairs and worries about dental insurance payment. Emerging economies, on the other hand, are likely to provide considerable profit prospects for market participants due to developments in the healthcare industry.

Competitive Environment

The global dental chairs market is fragmented and tremendously competitive for major competitors. To retain their positions, key market actors are emphasizing the quality of their products while releasing new things more often.

Existing technology advancements, product development and launches, and public awareness campaigns all contribute to a more competitive climate. Some of the most well-known players in the global dental Chairs industry are as follows: Austin Dental Equipment Company (A-Dec, Inc.), Midmar, Craftsmaster Contour Equipment, Inc., XO CARE A/S, and Sirona are among the companies involved.

• In June 2019, A-dec, announced the launch of the A-dec 500 dental chair brand. The company’s customer base is expected to increase as a result of the launch.

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15083

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Dental Chairs Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals extensive growth in Dental Chairs Market in terms of Type (Powered Dental Chairs, Non-powered Dental Chairs), by Product Type (Ceiling Mounted Design, Mobile Independent Design, Dental Chair Mounted Design), by Application (Examination, Surgery, Orthodontics, Other Applications) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Thyroid Function Tests Market is projected to grow at an average rate with a CAGR of 4.2 % from 2022-2032.

[250 Pages Report] During the forecast period 2022-2032, the thyroid function tests market is expected to grow at a CAGR of 4.2 percent on average.
Attributes Details
Thyroid Function Tests Market Size in 2022 US$ 1.68 Bn
Thyroid Function Tests Market CAGR during 2022-2032 4.2 %
Thyroid Function Tests Market: Regional Outlook
The global thyroid function tests market is expected to register a significant growth for the forecast period. Depending on geographic regions, the global thyroid function tests market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. As of 2015, North America and Western Europe dominated global thyroid function tests market in terms of market revenue. Asia Pacific & Japan is projected to grow at a substantial growth and will contribute to the global thyroid function tests market value exhibiting a robust CAGR during the forecast period, 2015-2025. 
Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-454Thyroid Function Tests (TFT) include various blood tests which are conducted to identify the functions of thyroid gland.

Epidemiological data from WHO suggests that there are more than 750 million cases globally with thyroid disorder. Several thyroid disorders such as Hypothyroidism, Hyperthyroidism, Hashimoto’s Disease, Grave’s Disease and Thyroiditis can be detected with the help of TFT. Hyperthyroidism and Hypothyroidism are two major indication of thyroid disorders. There are more than 250 million cases with hyperthyroidism globally. Around 60% of the population effected with thyroid disorder are unware of the situation. Female population are 5-6 times more likely to develop a thyroid disorder.

Thyroid Function Tests Market: Drivers & Restraints:

TFT is found to be very effective in diagnosing thyroid condition in patient. With the increase in prevalence of hyperthyroidism and hypothyroidism and increasing awareness among the patients, these tests are prescribed by all the physicians.  These tests also helps to diagnose auto-immune disorder, such as Hashimoto’s Disease, Grave’s Disease and Thyroiditis.

The TFT market is expected to growth at a significant growth in the forecast period (2016-2025) due to the various advantages offered by these test and favorable reimbursement facilities.

Thyroid function tests are very effective in diagnosing thyroid disorders. However, there are also a few potential challenges associated with them. The major challenge is setting the “normal range” for these tests. Given the risk/benefit perspective seems unclear, treatment decisions need to be individualized, based on the severity of individual symptoms.

Amongst all the healthcare facilities, hospitals are anticipated to account for majority of the TFT’s done worldwide.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-454

Thyroid Function Tests Market: Key Players

The key players in thyroid function testsmarket are Beckman Coulters, Siemens Healthcare Diagnostics, bioMérieux Inc, DiaSorin S.p.A and IBL-America and Others. The thyroid function testsmarket players can develop prospects in customized test solutions.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-454

Thyroid Function Tests Market: Segmentation:

The TFT market is broadly classified into three segments based on the disease indication.

  • TSH Tests (Thyroid Stimulating Hormone Test)
  • FT4 Tests (Free T4)
  • FT3 Tests (Free T3)

The overall TFT market is further segmented by usage of these tests in different healthcare facilities.

  • Hospitals
  • Acute Care Centers
  • Diagnostic Laboratories
  • Clinics

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Analgesics Market to register 5.6% CAGR during forecast period by 2031

As per a thorough research by FMI, the Global Analgesics Market is poised to top US$ 77.3 Bn in 2021. Increasing demand for opioid drugs for pain management in the countries such as China, India, the U.S., and Japan is facilitating the growth in the market.

Increasing need for palliative care and rising prevalence of neuropathic, inflammatory, and chronic pain is bolstering the demand for pain management solutions. Driven by this, the analgesics market is anticipated to surpass US$ 133.5 Bn by 2031.

Analgesics drugs such as methadone, codeine, acetaminophen, and others provide effective solutions to aforementioned ailments. Hence, increasing palliative care has assisted the market to account for nearly 93% of the pain management sales in 2021.

Further, rising government initiatives for providing better prevention and management of chronic pain are favoring the growth in the market. Also, growing prevalence of physiological injuries, phantom aches, and surgeries across China and India are accelerating the sales.

As per FMI, the analgesics market is poised to expand at 5.6% CAGR over the forecast period 2021-2031 in comparison to the 4.4% CAGR registered over the past half-decade.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1306

Based on drug type, the nonsteroidal anti-inflammatory drugs (NSAIDs) segment is projected to register swift growth, expanding at 4.1% CAGR between 2021 and 2031. Growing emphasis on prevention of diversion in prescription opioid medications is a primary factor driving the growth in the segment.

Key Takeaways from Analgesics Market Study

  • The U.S. is estimated to continue dominating the North America market, accounting for nearly 86.5% of the regional demand share in 2021.
  • Germany is anticipated to emerge as the most remunerative market in Europe, contributing nearly 23.2% of the sales through 2031.
  • China is expected to account for 54.3% of the share in East Asia, expanding at a robust CAGR of 9.3% over the assessment period.
  • Japan analgesics market is projected to register a swift growth, expanding at a CAGR of 6.6% between 2021 and 2031.
  • Surgical pain is forecast to account for the lion’s share in the indication segment, accounting for around 53.3% of the sales in 2021.

Key Drivers

  • Growing number of cancer treatments and rising commercialization of non-abusive drugs across the U.S., Japan, Germany, China, and others are spurring the sales in the NSAID segment.
  • Rising concerns of facial and body aesthetics are increasing aesthetic surgical procedures such as eyelid surgeries, breast implantation, and abdominoplasty, spurring analgesics sales across the surgical pain segment.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1306

Key Restraints

  • Side effects associated with opioid drugs such as clouded thinking, nausea, drowsiness, constipation, and psychological & physical addiction are hindering the sales across the opioid drug segment.
  • Stringent government regulations regarding manufacturing, storage, marketing, and selling analgesic drugs are restraining the growth in the market.

Competitive Landscape

Prominent companies in the global market are focusing of introducing novel non-opioid drugs to gain competitive edge. Some of the other players are focusing on entering in mergers, acquisitions, collaboration, and agreement with other manufacturers to expand their product portfolio and strengthen their global foot print. For instance,

  • In July 2020, Teva Pharmaceuticals, an Israeli multinational pharmaceutical company announced expanding its operations in Japan by focusing on commercializing a selection of complex generics and specialty assets to meet patients’ medical needs. This will assist the company to expand its customer base in Japan.
  • In May 2020, Assertio Therapeutics, Inc., an American specialty pharmaceutical company, entering into a merger agreement with a produces and distributes pharmaceutical products, Zyla Life Sciences to create a synergistic portfolio of neurology, inflammation, and non-opioid pain products. The merger will assist both the companies to expand their product portfolio and increase their market share.

Some of the key players operating in the market profiled by FMI are:

  • Pfizer Inc.
  • Sun Pharmaceutical Industries, Inc.
  • Sanofi SA
  • AbbVie Inc. (Allergan plc)
  • Teva Pharmaceuticals
  • Boehringer Ingelheim International GmbH
  • Janssen Pharmaceuticals, Inc. [Johnson & Johnson]
  • Endo Pharmaceuticals Inc.
  • Purdue Pharmaceuticals L.P.
  • Assertio Therapeutics, Inc.
  • Mallinckrodt Pharmaceuticals
  • Bayer AG
  • GlaxoSmithKline plc.
  • Bausch Health Companies Inc.
  • Novartis AG
  • Others

Ask For Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-1306

More Valuable Insights on Analgesics Market

The recent study by FMI provides a detailed analysis of the global analgesics market, providing credible insights into key factors driving the market over the assessment period. The study also disclosed growth projections on in analgesics market with detailed segmentation:

By Drug Class

  • Opioids
    • Morphine
    • Codiene
    • Fentanyl
    • Meperidine
    • Methadone
    • Tramadol
    • Oxycodone
    • Dextromethorphan
    • Buprenorphine
    • Others
  • NSAIDs
  • Local Anesthetics
  • Acetaminophen

By Indication

  • Surgical pain
  • Cancer Pain
  • Neuropathic pain
  • Others

By Route of Administration

  • Oral
  • parenteral
  • transdermal
  • Others

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Drug Stores
  • Online pharmacies

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Breast Imaging Market is projected to expand with a CAGR of 7.1% from 2022 to 2032

[343 Pages Report] The breast imaging market is expected to increase at a 7.1% CAGR from an anticipated USD 4.3 billion in 2022 to USD 8.5 billion by 2032.

Technological improvements, the rising prevalence of breast cancer, the increasing number of screening programs, and the increasing number of conferences and symposiums concentrating on spreading awareness about the advantages of early screening and diagnosis are all driving breast imaging market growth along with breast imaging market adoption trends.

Attributes Details
Breast Imaging Market CAGR (2022-2032) 7.1%
Breast Imaging Market Size (2022) US$ 4.3 Billion
Breast Imaging Market Size (2032) US$8.5 Billion

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14796

The rising breast imaging markets, increasing government and private investments to support the increasing demand for breast imaging, and a better reimbursement picture is likely to provide breast imaging market participants with a wide variety of breast imaging market key trends and opportunities prospects.

The National Cancer Institute conducts and encourages the development of recommendations for different organisations. Breast cancer is one of the most common causes of mortality among women.

As mammography is the standard procedure for screening breast cancer, governments and other healthcare organisations all over the world are taking steps to ensure that women have access to mammography screening. The global demand for breast imaging and mammography is expanding as a result.

There have been a lot of developments in the area that reduce over-diagnosis and improve sensitivity to identify tiny carcinomas. These ongoing improvements in this discipline are projected to boost the global breast imaging market‘s mammography segment.

The development and increased usage of improved mammography machines with novel technology are fueling breast imaging market future trends.

The Asia Pacific area is a prominent revenue generator in the breast imaging market. The rising prevalence of breast cancer, rising healthcare expenditure, an increase in the number of breast cancer awareness programs, and high government spending on breast cancer research studies in several Asia Pacific countries are the major factors driving the Asia Pacific breast imaging market opportunities.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-14796

KEY TAKEAWAYS:

  • In the United States, the breast imaging market is estimated to reach US$ 3.1 Billion by 2032, increasing at a CAGR of 6.9% through 2032.
  • The breast imaging market in the United Kingdom is expected to be worth US$ 350.3 Million by 2032, with a CAGR of 5.9% through 2032.
  • China’s breast imaging market is expected to reach US$ 613.6 Million by 2032, with a CAGR of 6.4% through 2032.
  • The market for breast imaging in Japan is expected to be valued at US$ 494.9 Million by 2032, expanding at a 5.4% annual rate through 2032.
  • South Korea is expected to reach a market size of US$ 308.8 Million in breast imaging by 2032, with a CAGR of 5.0% through 2032.
  • The breast imaging market’s ionizing breast imaging segment from the technology category is predicted to develop at a CAGR of 7.0% through 2032.
  • By 2032, the hospitals & clinics sector in the breast imaging market’s end-user category will grow at a CAGR of 7.0%.

COMPETITIVE LANDSCAPE:

New market research report on Breast Imaging says that Hologic, Inc., GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Canon Inc., Aurora Healthcare US Corp., Allengers, Dilon Technologies, Inc., Planmed Oy, Delphinus Medical Technologies, Inc., Micrima Limited, CMR Naviscan Corporation, SuperSonic Imagine, and Carestream Health., are among the legacy players vendors.

The research offers a comprehensive competition analysis of these top competitors in the breast imaging market, including breast imaging market growth, breast imaging market share, breast imaging market adoption trends and important market strategies.

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14796

Recent Development in the Breast Imaging:

  • Densitas Inc. announced collaboration with Mammography Educators, LLC in November 2020 to build an artificial intelligence-powered telehealth technologist training platform that would promote business continuity in mammography clinics.
  • Hologic, Inc. announced the commercial availability of 3DQuorum Imaging Technology powered by Genius AI in Europe in October 2020. According to the company’s disclosures, the 3DQuorum Imaging Technology uses Genius AI-powered analytics to reconstruct high-resolution 3D data. This technology aids in lowering picture interpretation time.

Key Segments

By Technology:

  • Ionizing Breast Imaging
    • Mammography
    • Positron Emission Tomography-Computed Tomography (PET-CT)
    • Molecular Breast Imaging (MBI)
    • Positron Emission Mammography (PEM)
    • Cone-beam Computed Tomography (CBCT)
  • Non-ionizing Breast Imaging
    • Breast Ultrasound
    • Breast MRI
    • Automated Whole-breast Ultrasound (AWBU)
    • Breast thermography
    • Electric Impedance Tomography
    • Optical Imaging

By End User:

  • Hospitals & Clinics
  • Diagnostic Imaging Centers
  • Breast Care Centers
  • Other End Users

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Cemetery Software Market is likely to amass a revenue of US$ 2.7 billion by 2032

[335 Pages Report] The cemetery software market is projected to move forward with a CAGR of 4%, reaching US$ 2.7 billion by 2032, up from US$ 1.8 billion in 2022 during the forecast period (2022-2032).

The global cemetery software market growth is likely to skyrocket due to rising demand for a growing number of digital natives, cloud-based cemetery software.

Attributes Details
Cemetery Software Market CAGR (2022-2032) 17.0%
Cemetery Software Market Value (2022) US$ 12.4 Bn
Cemetery Software Market Value (2032) US$ 59.8 Bn

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14809

Rising adoption of cemetery software is also facilitated by increased adoption of smart technology.

Growing awareness of the benefits of using cemetery software is a key factor driving the overall demand for cemetery software in various countries.

However, some end users’ reluctance to adopt new technologies may dwindle the cemetery software market size to some extent.

Nonetheless, during the forecast period, the global cemetery software market is expected to garner a healthy CAGR owing to its various benefits.

Some of which are that cemetery software generates a virtual map of a cemetery or burial facility to aid client selection and business allocation of burial plots, removing the need to traverse the physical grounds.

These maps are compatible with the majority of smartphones and laptop computers thereby significantly influencing the cemetery software adoption trends.

The cemetery software market trends are gaining momentum and the same can be owed to the increased use of Geographic Information Systems (GIS) for detailed mapping of unknown locations, including cemeteries.

This technology makes it easier to convert data into maps for greater accuracy, in turn, opening up a wide array of cemetery software market opportunities.

As cemetery software simplifies record digitization and storage by supporting image files, demand for cemetery software is on the surge worldwide.

Data can be retrieved quickly and displayed to clients for verification or correction and the same reduces the amount of manual paperwork and the potential for error.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-14809

The cemetery software market is segmented by type, application, and region.

By Type:

  • Cloud-Based
  • Web-Based

By Application:

  • Individual
  • Government
  • Funeral Home
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Key Players:

  • Cemify
  • Cemsites
  • Ovs-Genealogy
  • Legacy Mark
  • NewCom Technologies

These cemetery software companies play a significant role in bring about emerging trends in the market through various strategies including partnerships, mergers & acquisitions, collaboration, etc.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/14809

Key Takeaways:

  • The cemetery software market, based on type, is dominated by cloud-based segment with a CAGR of 4.0% from 2022 to 2032.
  • By application, individual segment is likely to take the lead at a CAGR of 4.1% during the forecast period as the cemetery software greatly assists individuals in managing the finances associated with cemetery maintenance.
  • The US cemetery software market is projected to account for a sizeable cemetery software market share of about US$ 1 billion by 2032.
  • By 2032, the UK cemetery software market is expected to be valued US$ 87.0 Million, growing at a CAGR of 2.7%.
  • With a CAGR of 3.4% during the forecast period, China cemetery software market size is predicted to account for US$ 192.1 million by 2032.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Blood Banking Equipment Market is set to reach a valuation of US$ 14.8 Billion in 2022

[300 Pages Report] According to Future Market Insights, the global blood banking equipment market held a valuation of about US$ 14.2 Bn in 2021. As per the study, sales are expected to increase at a CAGR of 4.7% during the forecast period (2022-2032), surpassing US$ 23.4 Bn in 2032.

Data Points Market Insights
Blood Banking Equipment Market Value 2021 US$ 14.2 Bn
Market Value 2022 US$ 14.8 Bn
Market Value 2032 US$ 23.4 Bn
CAGR 2022-2032 4.7% CAGR
Market Share of Top 5 Countries 50.7%

Need for blood components due to increasing surgical procedures and accidents has always been a matter of concern for blood banks and hospitals. In the U.K. the number of surgeries has been on the rise over the last few years. About 70,000 A&E cases were registered in 2019 in the country.  Such cases will mostly require surgical procedures and this will in turn demand more blood banking equipment and products.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14974

Increasing awareness about blood donation is the top priority of all blood transfusion centers. To address this issue, governments across the globe are offering several attractive reimbursement opportunities to volunteer donors.

For instance, the AABB promotes full insurance coverage and offers lucrative reimbursement that will support the patients’ access to blood products, transfusion services and cellular therapies. The blood banking equipment market will witness immense growth in the upcoming years if such policies are implemented by developing economies as well.

The development of the blood banking equipment market is reliant on automation in blood bank centers, the rising trend of mobile blood drives/ camps, government support and initiatives and an increasing number of blood donors.

Key Takeaways

  • Blood collection products are expected to hold a 8% market value share in 2022 and are projected to display a CAGR growth of 4.8% over the forecast period.
  • Hospitals hold a higher share in the blood banking equipment market by a value of about 3% in 2021.
  • North America is slated to be the largest leading region with a value share of 2% at the end of the forecast period
  • India is expected to lead the growth in South Asia blood banking equipment market during the assessment period.

“Rising prevalence of chronic blood-related disorders, along with increasing trend of blood donation drives will fuel the blood banking equipment market over the forecast period,” says an analyst of Future Market Insights.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-14974

Market Competition

Acquisitions, partnerships, recognition and product launches are the key strategies adopted by manufacturers and integrators to increase the consumer base in different geographies.

  • Blood Collection: BD acquired Velano Vascular in July 2021 with the goal of adding breakthrough needle-free blood draw technology to alleviate the pain and discomfort of multiple needlesticks.
  • Blood Processing: The novel plasma collection system developed by Terumo Blood and Cell Technologies received FDA approval in March 2022. Rika is a next-generation automated system that focuses on plasma centre personnel and donors’ experiences. It has safety features to reduce operator mistakes and harvests plasma in under 35 minutes.

Want More Insights

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032. The global blood banking equipment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the blood banking equipment market segment based on product– (blood collection [blood collection sets, blood bag tube sealer, blood collection mixer, blood bags, reagents, lancets, and others], blood processing [centrifuges, blood filters, blood bank analysers, blood warmers, and plasma thawing baths], blood storage [blood bank refrigerators, blood bank freezers, and test tube racks], and others), and end user (hospitals, and blood banks), across seven major regions.

Key Players :

  • Medtronic
  • BD Medical
  • Boston Scientific
  • Smith Medical
  • Argon Medical Devices
  • Novo Nordisk
  • Terumo Corporation
  • NIPRO Medical
  • B. Braun Melsungen AG
  • Medsurg
  • Hamilton Syringes & Needles
  • Hi-Tech Medicare Devices
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Cerus Corporation
  • CSL Behring LLC
  • Fresenius Kabi AG

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14974

Key Market Segments Covered in Blood Banking Equipment Industry Research

By Product:

  • Blood Collection
    • Blood Collection Sets
    • Blood Bag Tube Sealer
    • Blood Collection Mixer
    • Blood Bags
    • Reagents
    • Lancets
    • Others
  • Blood Processing
    • Centrifuges
    • Blood Filters
    • Blood Bank Analysers
    • Blood Warmers
    • Plasma Thawing Baths
  • Blood Storage
    • Blood Bank Refrigerators
    • Blood Bank Freezers
    • Test Tube Racks
  • Others

By End User:

  • Hospitals
  • Blood Banks

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com